152
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Development and effect of storage on the stability of enriched flavonoid fraction of Cecropia glaziovii-loaded PLGA nanoparticles

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon
Pages 998-1006 | Received 05 May 2016, Accepted 29 Sep 2016, Published online: 03 Nov 2016

References

  • Rescignano N, Tarpani L, Tiribuzi R, et al. Protein encapsulation in biodegradable polymeric nanoparticles: morphology, fluorescence behavior and stem cell uptake. Macromol Biosci 2013;13:1204–1212.
  • Goldberg M, Langer R, Jia X. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed 2007;18:241–268.
  • Belščak-Cvitanović A, Stojanović R, Manojlović V, et al. Encapsulation of polyphenolic antioxidants from medicinal plant extracts in alginate–chitosan system enhanced with ascorbic acid by electrostatic extrusion. Food Res Int 2011;44:1094–1101.
  • Chan ES, Yim ZH, Phan SH, et al. Encapsulation of herbal aqueous extract through absorption with ca-alginate hydrogel beads. Food Bioprod Process 2010;88:195–201.
  • Onwulata CI. Encapsulation of new active ingredients. Annu Rev Food Sci Technol 2012;3:183–202.
  • Matos J de A, Lorenzi H, Plantas Medicinais no Brasil: Nativas e Exóticas. 2nd ed. Instituto Plantarum de Estudos da Flora, editor. Nova Odessa; 2008:512.
  • Almeida RR, Raimundo JM, Oliveira RR, et al. Activity of Cecropia lyratiloba extract on contractility of cardiac and smooth muscles in Wistar rats. Clin Exp Pharmacol Physiol 2006;33:109–113.
  • Costa GM, Schenkel EP, Reginatto FH. Chemical and pharmacological aspects of the genus Cecropia. Nat Prod Commun 2011;6:913–920.
  • Silva IT, Costa GM, Stoco PH, et al. In vitro antiherpes effects of a C-glycosylflavonoid-enriched fraction of Cecropia glaziovii Sneth. Lett Appl Microbiol 2010;51:143–148.
  • Ortmann CF, Avaliação da estabilidade de extratos, fração e flavonoides C-glicosídeos presentes em Cecropia glaziovii [Internet]. Universidade Federal de Santa Catarina; 2013. Available from: https://repositorio.ufsc.br/handle/123456789/74645/browse?value=Ortmann,+Caroline+Flach&type=author.
  • Li M, Rouaud O, Poncelet D. Microencapsulation by solvent evaporation: State of the art for process engineering approaches. Int J Pharm 2008;363:26–39.
  • Regan JO, Mulvihill DM. Water soluble inner aqueous phase markers as indicators of the encapsulation properties of water-in-oil-in-water emulsions stabilized with sodium caseinate. Food Hydrocoll 2009;23:2339–2345.
  • Soares S, Fonte P, Costa A, et al. Effect of freeze drying, cryoprotectants and storage conditions on the stability of secondary structure of insulin-loaded solid lipid nanoparticles. Int J Pharm 2013;456:370–381.
  • Desai N. Challenges in development of nanoparticle-based therapeutics. AAPS J 2012;14:282–295.
  • Eidi H, Joubert O, Attik G, et al. Cytotoxicity assessment of heparin nanoparticles in NR8383 macrophages. Int J Pharm 2010;396:156–165.
  • Costa GM, Ortmann CF, Schenkel EP, Reginatto FH. An HPLC-DAD method to quantification of main phenolic compounds from leaves of Cecropia species. J Braz Chem Soc 2011;22:1096–1102.
  • Gaumet M, Vargas A, Gurny R, Delie F. Nanoparticles for drug delivery: The need for precision in reporting particle size parameters. Eur J Pharm Biopharm 2008;69:1–9.
  • Guterres SS, Poletto FS, Colomé LM, et al. Polymeric nanocapsules for drug delivery. Colloids Drug Deliv 2010;148:71–98.
  • Contado C, Vighi E, Dalpiaz A, Leo E. Influence of secondary preparative parameters and aging effects on PLGA particle size distribution: a sedimentation field flow fractionation investigation. Anal Bioanal Chem 2013;405:703–711.
  • Domingues GS, Guterres SS, Beck RCR, Pohlmann AR. Micropartículas nanorrevestidas contendo um fármaco modelo hidrofóbico: preparação em etapa única e caracterização biofarmacêutica. Quim Nova. SBQ 2008;31:1966–1972.
  • Lee D, Cho G, Lim HM, et al. Comparisons of particle size measurement method for colloidal silica. J Ceram Process Res 2013;14:274–278.
  • Zambaux MF, Bonneaux F, Gref R, et al. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J Control Release 1998;50:31–40.
  • Rao JP, Geckeler KE. Polymer nanoparticles: preparation techniques and size-control parameters. Prog Polym Sci 2011;36:887–913.
  • Wang S, Guo S. Disodium norcantharidate-loaded poly(epsilon-caprolactone) microspheres II. Modification of morphology and release behavior. Int J Pharm 2008;353:15–20.
  • O’Regan J, Mulvihill DM. Sodium caseinate-maltodextrin conjugate stabilized double emulsions: Encapsulation and stability. Food Res Int 2010;43:224–231.
  • Fessi H, Puisieux F, Devissaguet JP, et al. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm 1989;55:1–4.
  • Mishra B, Patel BB, Tiwari S. Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomed Nanotechnol Biol Med. Elsevier Inc 2010;6:9–24.
  • Lepeltier E, Bourgaux C, Couvreur P. Nanoprecipitation and the Ouzo effect: application to drug delivery devices. Adv Drug Deliv Rev 2014;71:86–97.
  • Arpicco S, Battaglia L, Brusa P, et al. Recent studies on the delivery of hydrophilic drugs in nanoparticulate systems. J Drug Deliv Sci Technol 2015;32:298–312.
  • Bilati U, Allémann E, Doelker E. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur J Pharm Sci 2005;24:67–75.
  • Judefeind A, Villiers MM. d. Drug loading into and in vitro release from nanosized drug delivery systems. Nanotechnol Drug Deliv 2009;X:129–162.
  • Chu KS, Schorzman AN, Finniss MC, et al. Nanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacy. Biomaterials 2013;34:8424–8429.
  • Govender T, Stolnik S, Garnett MC, Illum LDS. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release 1999;57:171–185.
  • Kashi TSJ, Eskandarion S, Esfandyari-Manesh M, et al. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method. Int J Nanomedicine 2012;7:221–234.
  • Vandervoort J, Ludwig A. Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study. Int J Pharm 2002;238:77–92.
  • Bala I, Hariharan S, Kumar MNVR. PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carrier Syst 2004;21:387–422.
  • Quintanar-Guerrero D, Allémann E, Fessi H, Doelker E. Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm 1998;24:1113–1128.
  • Demerlis CC, Schoneker DR. Review of the oral toxicity of polyvinyl alcohol (PVA). Food Chem Toxicol 2003;41:319–326.
  • Wang YC, Wu YT, Huang HY, Yang CS. Surfactant-free formulation of poly(lactic/glycolic) acid nanoparticles encapsulating functional polypeptide: a technical note. AAPS PharmSciTech 2009;10:1263–1267.
  • Martín Banderas L, Álvarez Fuentes J, Durán Lobato M, et al. Cannabinoid derivate loaded PLGA nanocarriers for oral administration: formulation, characterization, and cytotoxicity studies. Int J Nanomedicine 2012;7:5793–5806.
  • Santander-Ortega MJ, Jódar-Reyes AB, Csaba N, et al. Colloidal stability of Pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms. J Colloid Interface Sci 2006;302:522–529.
  • Gad SC. Pharmaceutical manufacturing handbook: regulations and quality. Vol. 1. Wiley. 2008;1–841.
  • Singh R, Lillard JW. Nanoparticle-based targeted drug delivery. Exp Mol Pathol 2009;86:215–223.
  • Dash S, Murthy PN, Nath PCL. Review: kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm 2010;67:217–223.
  • Aksungur P, Demirbilek M, Denkbaş EB, et al. Development and characterization of cyclosporine A loaded nanoparticles for ocular drug delivery: cellular toxicity, uptake, and kinetic studies. J Control Release 2011;151:286–294.
  • Ranjan AP, Mukerjee A, Helson L, Vishwanatha JK. Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy. J Nanobiotechnol 2012;10:38.
  • Li D, Kaner RB. Shape and aggregation control of nanoparticles: not shaken, not stirred. J Am Chem Soc 2006;128:968–975.
  • Abdelwahed W, Degobert G, Fessi H. Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage. Eur J Pharm Biopharm 2006;63:87–94.
  • Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev 2006;58:1688–1713.
  • Honary S, Jahanshahi M, Golbayani P, et al. Doxorubicin-loaded albumin nanoparticles: formulation and characterization. J Nanosci Nanotechnol 2010;10:7752–7757.
  • Honary S, Zahir F. Effect of zeta potential on the properties of nano - drug delivery systems - a review (Part 2). Trop J Pharm Al Res 2013;12:265–273.
  • Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel) 2011;3:1377–1397.
  • Zolnik BS, Burgess DJ. Effect of acidic pH on PLGA microsphere degradation and release. J Control Release 2007;122:338–344.
  • Vineeth P, Rao Vadaparthi PR, Kumar K, et al. Influence of organic solvents on nanoparticle formation and surfactants on release behavior in-vitro using costunolide as model anticancer agent. Int J Pharm Pharm Sci 2014;6:638–645.
  • Narita Y, Inouye K. Degradation kinetics of chlorogenic acid at various pH values and effects of ascorbic acid and epigallocatechin gallate on its stability under alkaline conditions. J Agric Food Chem 2013;61:966–972.
  • Talhi O, Silva AMS. Advances in C-glycosylflavonoid research. Curr Org Chem 2012;16:859–896.
  • Kerleta. Pluronic® F-68 Enhances the Nanoparticle-Cell Interaction. Sci Pharm 2009;77:179–179.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.